California: Scale up your Biotech, Medtech and Digital Health business in Irvine, Orange County
2019-02-13 15:00 - 17:00 (Europe/London) | London & Partners 2 More London Riverside London SE1 2RR
To help British companies explore business opportunities in Southern California
London & Partners are organising a panel discussion with the city of Irvine/Orange County, involving a senior delegation of business, life science, technology and funding experts, in collaboration with OneNucleus, the Association of British Healthtech Industries (ABHI), TechUK, the UK Department of International Trade (and more partners).
The goal of this third mission to the U.K. is to build awareness for Irvine/Orange County and its life science/technology industry strength and identify, connect with and encourage U.K.-based life science companies to look at Irvine/Orange County when they consider setting up a subsidiary in the U.S. and California.
Why attend?

UK and Irvine/Orange county Life Science ecosystems:

There is great potential for exchanging expertise between the U.K. and Orange County clusters in how the regional ecosystem can be facilitated in creating and growing world class life science technology companies in biotech, medtech and digital health.

Raise funds in California:

Information on how to access the biggest Angel and Venture capital network in the US to scale up your company.

Access to a world class talent pool and business support:

The depth of the Irvine cluster in this field means it represents an excellent pool of talents, investors and partners for UK-based companies seeking to set-up operations in the US
Programme:
14.30 – Arrival and Registration
15.00 – Welcome remarks by The Honorable Don Wagner, Mayor of Irvine
15.10 – Introduction of Irvine, Orange County and the Southern California ecosystem
15.20 – Panel Discussion with industry experts: “Building the Life Science & Med Tech ecosystem to accelerate success”
16.10 – Short break
16.20 – Panel Discussion with industry experts: “Scale-up your business in California: support available from accelerators, industry associations and government agencies”
17.10 – Networking
Moderator:
Linda Di Mario, Executive Director of Irvine Greater Chamber of Commerce
Speakers from California will include:
Bryan Starr, Greater Irvine Chamber, President & CEO
Leigh Volkland, Edwards Lifesciences, Senior Director, Government Affairs
Dr. Sesha Neervannan, Senior Vice President, Pharmaceutical Development, Allergan
Bill Carpou, OCTANe “Building the SoCal of Tomorrow”, CEO
Dr. Steven Small, University of California Irvine Medical Center, Medical Innovation Institute Chief Scientific Officer
Speakers from the UK will include:
A representative from Mayor’s International Business Programme (speaker TBC)
A representative from the Department for International Trade (speaker TBC)
A representative from ABHI (speaker TBC)
A representative from TechUK (speaker TBC)
A British company in Life Science / Digital health with a presence in Irvine (speaker TBC)
Want individual appointments with the Irvine/Orange County delegation?
Four full days of meetings with U.K. companies are being planned on 11-14 February, just select the “individual appointment” ticket option.
About us:
Life Sciences in California
A major industry Home to Life sciences innovators including companies, laboratories and academic research institutes – employing 281,000 people in 2,848 companies and generating $130b annual revenue. Easy access to capital with 60% of the $62b venture capital in life sciences nationwide going to California based companies – Irvine Chamber has a network of partners in Venture Capital, Angel Networks and the banking community ready to work with you.
Life Sciences in Irvine/Orange County
Cutting edge R&D – Irvine and Orange County became a hotbed for the life science industry initially in the 1950s. Today it has 1,100 life science companies, employing more than 43,000 persons generating $35.3b annually. Irvine has one of the top 100 universities on the Shanghai Index: University of California in Irvine (UCI).
Major companies: Edward Lifesciences, Medtronic Heart Valves, Toshiba America Medical Systems Inc, Baxter International Inc, Allergan Inc, Teva Pharmaceuticals Industries, Avid Bioservices, Inc.
Technology ecosystem – Irvine has innovative start-up ecosystem and launch pads (such as OCTANe, which connects new medical innovators to angel investors) specialising in medical devices and biotechnologies with a cost of business 50% less than Silicon Valley.
Greater Irvine Chamber of Commerce
We help businesses connect with people, resources, new markets, customers and capital. We encourage and nurture startups. We advocate for business interests. We pave the way for business success. We help foreign-owned companies find a “home” in Irvine/Orange County, California.
In collaboration with an impressive network of public and private companies and organizations are ready to offer qualified life science companies a resource-rich package of decision-making incentives and transition benefits.

Special Interest Group on Infection Prevention
2019-02-14 09:30 - 13:30 | Belton Woods Hotel, Belton Grantham, NG32 2LN United Kingdom
If you’re interested in Infection Prevention, then this Special Interest Group will be of interest to you.
Drawing on leading speakers and researchers in Infection Prevention, this event will cover important topics such as:
– Understanding the role of disinfectants and how resistance mechanisms are developed
– Technological advances in detection of contamination and disinfection
– Testing and development of antimicrobials for resistance in MRSA
– Comparing persistent and non-persistent infections and their treatment
The event will be highly interactive and opportunity will be given to engage with both speakers and other delegates.
Opportunities available to present for 5 minutes to showcase your products/services that are relevant to this event – click here to email your interest.
This free to attend event is being held by Medilink EM and the East Midlands Academic Health Science Network, under our joint project LARIS (Lincolnshire & Rutland Innovation Support). The project aims to provide Innovation Support for Medical and Life Science businesses based in Lincolnshire & Rutland – to find out more, click here.
Programme

Brexit Briefing
2019-02-21 08:00 - 10:00 | Discovery Building, BioCity Nottingham, NG1 1GF
This breakfast event in partnership with Maetrics Ltd and Shakespeare Martineau LLP will provide an invaluable opportunity to find out the key legal and regulatory issues impacted by Brexit.

Programme

This event is free to attend, spaces are limited and priority will be given to members of Medilink

Bio Wales Showcase
2019-02-27 12:00 - 18:00 | Rocket Space, London
For a small country, Wales has a lot to offer.
From company success stories, to strong links between industry and academia; a thriving Research and Development community; compelling inward investment proposition and a Life Sciences Hub to drive effective solutions for health and care services in Wales, we have established firm foundations, although want to go further!
Wales Week in London provides the perfect opportunity to share Wales with you and forge new relationships to accelerate innovation and economic benefit.Welsh Government want to start that conversation at our showcase event, and networking lunch and drinks reception.
Speaker Programme:
Professor Keith Harding – Medical Director, Welsh Wound Innovation Centre
Mark Briggs – Head of Cell and Gene Strategy, Welsh Blood Service
Professor Krish Singh – Head of Human Electrophysiology, CUBRIC
Phillip Webb – Planning and Performance, Velindre NHS Trust
Gareth Healey – Project Manager, CALIN
Professor Steve Conlan – Head of Innovation, Swansea School of Medicine
Mike Moran – CEO, Proton Partners
Simon Tyler – COO, CatSci
Email LifeSciences@gov.wales to register your interest
For more information please visit: https://walesweek.london/whats-on/innovate-engage-inspire-this-is-life-sciences-this-is-wales

Sensing and Imaging for diagnostics, detection and monitoring
2019-02-28 09:00 - 13:30 | NOTTS COUNTY FOOTBALL CLUB, MEADOW LANE STADIUM, MEADOW LANE, NOTTINGHAM, NG2 3HJ, United Kingdom
This event will share a wide range of developments in sensing and imaging technologies which can be used in new medical devices to improve diagnostics, detection and monitoring of clinical signs.
Presentation topics include:
– Sensing inside the cell with miniaturised analytical devices
– Sensing and imaging at micro and nano-scales using non-invasive biophotonic techniques: for diagnosis, toxicity assessment and other clinical uses
– Optical and physiological monitoring – from textiles to critical care to surgical instrumentation
– From sensing data to advanced diagnostic and therapeutic tools focussing on data analysis
– Utilising 3D tracking technology and systems for healthcare diagnostics, detection and monitoring
Plus the whole process of developing medical devices from bench to bedside will be discussed combining industry, academia and NHS input with the opportunity to explore new collaborations
This free to attend event is being held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project.
Programme
Book Now

4TH Annual MarketsAndMarkets Infection Control, Sterilisation & Decontamination In Healthcare Congress
2019-02-28 09:00 - 2019-03-01 15:00 | Hotel Novotel London West, Hammersmith International Ctre 1, Shortlands, London, W6 8DR
4th Annual MarketsandMarkets Infection Control, Sterilization & Decontamination in Healthcare Congress will address issues associated with decontaminating process efficacy and infection free hospital environment.
The congress will take place on 28 February – 1 March 2019 in London – UK.
You can view the post show report for the 3rd Annual Infection Control, Sterilization & Decontamination here
As quoted by House of Commons Library on 14 May 2018 “UK healthcare-associated infections cost lives and money. Some 300,000 healthcare-associated infections every year cost the NHS in excess of £1 billion annually”
The increasing use of antibiotics in medicine prescription around the world is constantly causing bacteria to mutate and become resistant to drugs. Also, every surgical instrument has their own set of procedures for cleaning, as stated by their manufacturer.
There are lot of efforts taken by NHS to reuse device related Healthcare Associated Infections through their standardized training and effective decontaminating process, but the main issues are- are we really implementing our process and reaching efficacy in decontamination and making the hospital environment infection free.

KEY HIGHLIGHTS

Detailed coverage on Sepsis | Constructive talk on Antimicrobial Resistance | Effective management of Upper Respiratory Infections and CJD | Dealing and preventing Healthcare Associated Infections | Misfolded protein related diseases as from the perspective of decontamination and infection control | Reprocessing of flexible endoscope and difficult surgical instruments | Comparative case study on UVC Room decontamination – using Fumigation technologies or UV based room treatment systems | Clean water system for effective decontamination

WHO SHOULD ATTEND

Infection Control:
Directors | Heads | Doctors | Nurses | Specialists | Consultants
Decontamination:
Clinical lead | Consultants | Manager | Deputy Manager | Site Manager | Director | MD | Service Manager | General Manager | Technical advisor | Heads | Central Decontamination | Trainers
Sterilization:
CSSD (Central sterile service department) | Head of Sterile services | Consultants | Manager | Deputy Manager
Endoscopy Managers
Quality Improvement Managers
From Hospitals, Home Care, Research Institutes and Universities

Head over to the website to choose your plan: http://events.marketsandmarkets.com/4th-Annual-Infection-Control-Sterilization-Decontamination-in-Healthcare-Congress/

2ND Annual MarketsandMarkets Infectious Diseases Diagnostic Conference
2019-02-28 09:00 - 2019-03-01 15:00 | Hotel Novotel London West, Hammersmith International Ctre 1, Shortlands, London, W6 8DR
After the success of inaugural congress held on 21st -22nd February 2018, MarketsandMarkets is organising 2nd annual MarketsandMarkets Infectious Diseases Diagnostic Conference to be held on 28th February – 1st March 2019 in Central London, UK
According to the World Health Organization, 17 million deaths are caused each year by infectious diseases, accounting for nearly 30% of the annual mortality rate worldwide.
Lower respiratory tract infections, HIV/AIDS, gastro-intestinal diseases, malaria and tuberculosis are together responsible for nearly one-third of all deaths. Various technological developments and advancements in vitro diagnostics have led to a new variety of diagnostic tests, allowing patients to access novel treatments earlier.
This conference aims to bring different stakeholders together from hospitals, laboratories, academic institutes and IVD industry leaders to discuss about the emerging technologies and potential growth of molecular diagnostics and challenges faced in point-of-care testing and antimicrobial resistance. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced.

KEY HIGHLIGHTS

Discussion on the treatment and diagnosis of fungal infection, flu, Hepatitis C | Antibiotic Resistance: Consequences of overtreating infectious disease | Talks on Neglected Tropical Diseases (NTDs) diagnostic | Rapid TB/Ref R testing | The clinical need for better antimicrobial resistance related diagnostics | Treatments of MDR gram negative bacteria | Time required to diagnosis vancomycin-resistant enterococci (VRE)

WHO SHOULD ATTEND

From Hospitals, Reference Laboratories, Research Institutes and Academics
Directors, head of laboratory, Lab Managers, Deputy Lab Managers, Chief/Head Biomedical Scientist, Laboratory Technician, Professors, Associate Professors, Research Fellow, POCT lead, Consultant Microbiologist, Nurses, Professors, Clinical Services.
Departments:
Pathology | Molecular pathology | Biochemistry/ Clinical biochemistry | Microbiology/ Clinical Microbiology | Molecular Biology | Virology | Infectious diseases | Point of care testing | Infection Control
Why attend?
Find out new developments and emerging methods of diagnostics for infectious disease | Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you | Explore the latest platforms and technologies on the market for development | Discuss the best tool for your research in pathology | Share your work and achievements with your industry peers in the Poster Session

To choose your plan head over to the event website: http://events.marketsandmarkets.com/2nd-annual-infectious-diseases-diagnostics-conference/

Welsh Life Science Showcase
2019-03-06 10:00 - 18:30 | CMS Cameron McKenna Nabarro Olswang LLP, Cannon Place 78 Cannon Street, London, EC4N 6AF
Agenda:
10.00 Registration
10.30 Welcome from the Hosts, One Nucleus and MediWales

10.45 Panel Discussion – Trends in Life Sciences – Research, Business and Politics
Chair: Gwyn Tudor, CEO, MediWales
Panellists – Hamish Laing Swansea University, Richard Thompson Development Bank of Wales

11.30 Oncology in Wales
Wales Cancer Research Centre: opportunities for translational and clinical collaboration, John Chester, University of Cardiff
Matthew Harris, Health and Care Research Wales
Advanced Therapeutics, Alan Parker, University of Cardiff
Mark Treherne, Cellesce

12.30 Neuroscience in Wales
Simon Ward, Director of Medicines Discovery Institute, University of Cardiff
Shaun Stapleton, Reneuron

13.00 Lunch and networking

14.00 Innovation Showcase
Cotton Moulton Diagnostics – Jenner Bowen
Imspex – Emma Brodrick
Innoture – Michael Graz
Swansea University, Deya Gonzalez,

15.00 Cell & Gene Therapy
PCI Services
Reneuron (tbc)
World Courrier
Trakcel
Welsh Blood Service (tbc)

16.00 Tea/coffee break

16.30 Innovation Showcase
Forth for Life – Sarah Bolt
NEEM Biotech – Graham Dixon
Jellagen – Andrew Mearns Spragg
Respiratory Innovation Wales- Kevin Smith

17.30 Closing Remarks

17.40 Drinks Reception

18.30 Close

mHealth App National Workshop
2019-03-06 12:30 - 16:45 | Hempsons, 100 Wood Street, London, EC2V 7AN, United Kingdom
SEHTA and ORCHA are holding this workshop on mHealth Apps to help innovators working on app development for mHealth Apps to understand the technical requirements and evaluation for your innovation.
Date: Wednesday 6th March
Venue: Hempsons, 100 Wood Street, London, EC2V 7AN
Times: 12:30 – 16:45
Cost to attend: SEHTA Members £149 + VAT / Non-members £199 + VAT
This workshop will also be run by Medilink East & West Midlands & Medilink North of England during 2019. Check out their websites for further details.
Venue kindly supported by

The NHS and national health bodies across the world are revolutionising services through the integration of digital health solutions, leading to more patient-centred and efficient care. Frameworks guide the identification of health apps that will safely make the biggest impact in terms of improving outcomes.
As a developer, it can be hard to know what technical requirements and evaluation will be imperative, and how to navigate the system to ensure the right people know about your innovation.
This workshop aims to give developers clear guidance, helping to get to the right market with the right product, fit for NHS and worldwide quality standards.
Come and be part of the day, to learn:

What the app accreditation landscape is across the UK, EU and globally
What interoperability and data sharing with clinical data sets is and what it means for you?
How to get traction in the NHS and the public sector
How to build a ROI case for your product

The day will consist of quick pace presentations followed by panel discussions. Be ready with your questions!

Please note that places are limited & the organisers have the right to review all applications. Confirmation will be sent by 22nd Feb and invoices will be sent separately by SEHTA.
Please note that in compliance with our GPDR policy, by registering for this event, you are automatically added to our mailing list. If you wish to unsubscribe email info@sehta.co.uk with your details.

Time
Programme

12.30 – 13:30
Registration & Networking Lunch

13:30 – 13:40
Welcome and introduction to the mHealth market place: MedTech and Apps
Liz Ashall-Payne, CEO, ORCHA & Dr David Parry, CEO, SEHTA

13:40 – 14:10
National perspective mHealth
Speakers TBC

14:10 – 14:30
mHealth App interoperability
What are the foundations for achieving data integration and an interoperable Ecosystem?

What is interoperability?
Why is it important?
EU Voluntary Code of Conduct on mHealth Apps
Market Perspectives
The Digital Health Society

Bleddyn Rees, Digital Health Consultant, Obsourne Clarke

14:30 – 15:00
mHealth Regulation and Technical Safety
What are the current regulations and what new requirements are coming shortly for mHealth?
Tim Andrews, COO, ORCHA & Speaker TBC

15:00 – 15:30
Refreshment Break

15:30 – 16:00
Apps in Clinical Practice
How and where are Apps being used in clinical practice today? And what are the barriers and opportunities to making mHealth part of what is done in everyday clinical practice?
Dr Chris Mimnagh, GP, Clinical Safety Officer

16:00 – 16:30
Sustainable commercial models for mHealth
What is required to achieve a sustainable business model which drives value and revenue in mHealth?
Simon Leigh, Health Economist, ORCHA

16:30 – 16:45
Final comments and next steps
Liz Ashall-Payne & Dr David Parry

16:45
Close

Food Supplements Special Interest Group (SIG)
2019-03-07 09:00 - 13:00 | Discovery Building, BioCity Nottingham, NG1 1GF
Probiotics and the Gut Microbiome.
As part of a two part special interest group initiative, Farm to Fork, with our sister SIG, Infectious Disease (co-ordinated by Dr Katie Laird, DMU) we are looking at the nutrition perspective of microbiology, namely probiotics and why a healthy gut is important. Micro-organisms are integral to our health and wellbeing. In these two networking meetings we shall be exploring how the role of micro-organisms both good and bad are pivotal to our continued health.
7 March – This event will look at the impact of the microbiome, influence of probiotics (what they are and how they are regulated) and how to innovate in this area.
This free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project.
Please note: Individual registration is required for each event. By clicking BOOK NOW you will be registered for 7 March only.
3 April – The Infectious Disease SIG will explore the links between food production and antibiotic resistance in the environment and the impact this can have on health. Click here for further details.
Programme
Book Now

Concept Development and Quality Management Systems
2019-03-07 09:30 - 16:00 | Medilink West Midlands, 4 Greenfield Crescent, Edgbaston, Birmingham , B15 3BE
Medilink Members fee: £180 + VAT
Non Medilink Members fee: £215 + VAT
15% Christmas bonus discount will be applied to all bookings made before 5 January 2019!
This one-day event will:-
-Provide you with an overview of the requirements for the concept design phase of a medical device
-Assist you in assessing your company’s current readiness for implementing a QMS
-Give you a clear, practical guide to the next steps that you and your company need to take to move
through to the next design phase
Outcomes
-Understand the key areas of concept development required
-Gain an overview of the regulatory and quality management system requirements for a concept
medical device
-Understand the technical documentation that should be in place for this stage of device
development
-Explore early stage risk management and next steps planning

BOOK NOW

Women in Leadership, Innovation and Entrepreneurship
2019-03-07 10:00 - 15:00 | Unnamed Venue, Swansea
International Women’s Day is a global day celebrating the social, economic, cultural and political achievements of women. The day also marks a call to action for accelerating gender parity and the race is on to build a more gender-balanced world – #BalanceforBetter
In celebration of International Women’s Day, this event will focus on the theme of Women in Leadership, Innovation and Entrepreneurship; it will showcase some of the extraordinary successes women in Wales have had over recent years, along with exploring the breakthrough’s being made in terms of gender equality, and some of the main challenges that still exist today that we can work together to address. The event is open to all, free to attend, and includes the following line-up:

10.30 – 10.45 Welcome and Introduction to Athena Swan at Swansea University; Professor Hilary Lappin-Scott OBE, Senior Pro-Vice Chancellor
10.45 – 11.00 Laura Baker, Head of Product Management & New Product De-velopment, Tata Steel UK
11.00 – 11.15 Sarah John, Founder, Boss Brewery Co
11.15 – 11.25 Dr Geertje Van Keulen, Best Women in STEM Award Winner
11.25 – 11.35 Professor Catherine Thornton, Deputy Head of Swansea University Medical School
11.35 – 11.50 Victoria Bates, Healthcare Operations Director, Pfizer
11.50 – 12.05 Cari-Anne Quinn, CEO, Life Science Hub
12.05 – 12.15 Professor Shareen Doak, Swansea University Medical School
12.15 – 12.35 Speaker Q&A
12.35 – 13.25 Lunch and Networking
13.25 – 13.45 Julie James AM, Welsh Government
13.45 – 14.00 Fiona Spowers, Director, Riversimple
14.00 – 14.30 In Conversation with14.30 – 14.40 Professor Gwyneth Davies, Swansea University Medical School

Hannah Lamden, Finery Media
Canisha Chakadya – Phoenix Subscriptions

14.40 – 14.55 Rayner Davies, A&R Cleaning Services
14.55 – 15.00 Closing Remarks; Professor Hilary Lappin-Scott OBE, Senior Pro-Vice Chancellor
15.00 Finish & Networking

Delivered in collaboration with Swansea University: LINC, The Morgan Academy, Athena SWAN, ION Leadership, CALIN, BEACON and colleagues across Swansea University.

Trade Mission to Japan and South Korea
2019-03-11 - 2019-03-17 | Japan & South Korea
Join the DIT Trade Mission to South Korea and Japan to gain insight into opportunities in these 2 markets, expand your business potential and cultivate a network of contacts within the Korean and Japanese Medtec industries.
The Department for International Trade are coordinating a trade mission to Tokyo and Seoul. During this activity companies can take part in the following activity:

Exhibit at KIMES 2019: Use of a shared meeting and exhibition space on DIT stand. This shared 36sqm space offers companies communal meeting space, UK branding and individual company marketing displays.
Market Briefing S.Korea: Briefing and information session at British Embassy in Seoul.
Networking Reception S.Korea: Distributors, agents, academics, clinicians and key government affiliates will be invited to this British reception.
Seminar Japan: Participants will have the opportunity to present for 15 minutes at the British Embassy in Tokyo to a selected audience of over 50 Japanese representatives. Simultaneous translation will be provided along with the translation of company profiles.
Market Briefing Japan: Briefing and information session at British Embassy in Tokyo. This will be followed by a visit and tour around a local hospital.

Participation Costs
This trade mission is split into two parts, giving companies the flexibility to visit just one market or both markets and engage with the activity most valuable to their organisation.
South Korea£2,500 – This cost includes all in market activity, use of the shared exhibition stand space and accommodation close to the KIMES exhibition. TAP grants of £2,500 are available to eligible companies.
Japan£770 – This cost includes all activity in Tokyo and support from DIT in market team. Additional activity and an extension of the programme can be discussed individually if required.
*All travel arrangements must be made and paid for by the delegate (advice and support will be offered)**TAP grants are available on a first come first served basis to eligible UK based companies***All prices are exclusive of VAT

How to Join
Please register your interest by completing the online application form:https://exporttojapan.co.uk/events/medtech-mission-to-kimes-south-korea-and-japan/
The deadline for expressing interest in this trade mission is Friday 18th January 2019.
For more information, please contact:DIT Korea – Eunjung.lee@fco.gov.ukDIT Japan – lifesciencetradejapan@mobile.trade.gov.ukMedilink – t.elliott@medilink.co.uk

Why Go to Japan and South Korea?
South KoreaThe South Korean medical devices market is the 9th largest in the world, valued at valued at £4.4 billion. The market is continuously growing with CAGR of 6.3%. The healthcare system in the country is known to be high quality and efficient, with the Korean National Health Insurance System (KNIS) providing near universal healthcare coverage to the population of 51 million. Relatively high consumption of alcohol and tobacco, plus increasingly sedentary lifestyles and an ageing population means Korea faces a growing burden of non-communicable disease and is reliant on new technologies to keep up with the population’s needs.
Korea has a lot of opportunities for UK companies, particularly for products using cutting edge technology in digital health, orthopaedics, wound care, dental, ophthalmic products and elderly care. Local firms and hospitals have expressed interest in products such as dental implants, ultrasound imaging systems, grafts/prostheses, biomaterials, and PACS. There is a strong appetite for UK products, with the UK ranking as 7th in the list of biggest importers to Korea in 2016.
JapanJapan’s medical devices and healthcare market offers business opportunities for innovative British companies. It is the second largest medical devices market after the US with a large number of hospitals. It offers universal access and national healthcare services, and the world’s highest life expectancies. Premium pricing is also available for healthcare innovations. Japan’s medical devices market, valued at over £20 billion, heavily relies on imports, especially for therapeutic devices, which consist of nearly 50% of the total domestic sales volume. The UK is ranked as the 8th largest exporter of medical devices to Japan. Also, since the revision of the Pharmaceutical and Medical Devices Act in 2014, regulations on medical devices have been modified to allow faster and easier access to the Japanese medical devices market. Japan’s approval process is now roughly equivalent to the US.
Japan offers a great opportunity for UK companies involved in the development of innovative medical technology, particularly in the following areas: artificial internal organ apparatus and assistive devices, high tech operating equipment and supplies, ophthalmic goods, diagnostic imaging system; therapeutic and surgical equipment and home treatment equipment.

International trade in 2019 and beyond
2019-03-12 08:30 - 11:30 | Two Snowhill, Birmingham B4 6WR
Tuesday 12 March, Gowling WLG office Birmingham
Booking link: https://www.medilinkwm.co.uk/events/international-trade-in-2019-and-beyond/

The future of the UK’s international trade landscape remains unclear. There are still questions as to where we are heading in terms of the UK-EU relationship. This poses a number of challenges for businesses that are dependent on cross border trade with the EU, and require an understanding of what measures can be taken to keep goods moving across the border, in the event of a No Deal Brexit. In parallel to the EU-UK negotiations, there are discussions underway that would potentially lead the UK to forming or extending trade relationships with other territories. These new trade arrangements, so called Free Trade Agreements “FTA”s, will offer new or improved market access opportunities for those businesses that are positioned to take advantage and understand the requirements placed on an exporter of goods or services.

Whilst it is not possible to predict the Brexit status by the 12 March, undoubtedly a viewpoint on the common challenges and opportunities around international trade and the associated compliance requirements will be invaluable. The agenda below has been kept deliberately open and will be flexed according to the position of the UK and Brexit at the time. This event will be hosted by Ursula Johnston and other trade and regulatory specialists who will be on hand to answer any questions you may have.

Brexit update and what does the current position mean for the Life Sciences sector;
Customs compliance for cross border trade: common challenges and solutions;
An introduction to Free Trade Agreements;
International trade, contracts and Incoterms; and
Adapting to a new regulatory environment.

This event is in partnership with Gowling WLG and Medilink West Midlands.
Hot drinks and pastries will be available on arrival.

Smart Materials in Healthcare
2019-03-12 09:00 - 13:30 | Woughton House, Newport Road, Woughton on the Green, Milton Keynes, MK6 3LR, United Kingdom
This event will look at the applications of smart materials in healthcare.
This free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project.
Presentations will include:
– Novel nanoparticle radiosensitisers for cancer therapy
– Electrospun nanomaterials for drug, nutrient and packaging applications
Programme

Health Technology Assessment (Online Workshop)
2019-03-12 09:30 - 12:30
Health Technology Wales (HTW) has collaborated with Life Sciences Hub Wales (LSHW) to introduce you to key concepts and methods in Health Technology Assessment and Health Economics, through two interactive and free workshops.
Advances in health technologies will have a major impact on the future of health and social care in Wales.
Both workshops will use live examples from HTW, the body responsible for producing national guidance to maximise value and optimise use of technologies that will improve health and care in Wales.
Our Health Technology Assessment (HTA) workshop will introduce you to key methods used to appraise health technologies and understand their potential value to service users, providers and technology partners.

Future Healthcare 2019 - Exhibition and Conference
2019-03-18 09:00 - 2019-03-19 17:00
Organised in association with UKIHMA – a strategic partner of Healthcare UK, a UK government trade promotion organisation jointly funded by the Department for International Trade, the Department of Health and NHS England. Future Healthcare is the UK’s largest exhibition and conference showcasing products and services across all vertical sectors that will contribute to our future healthcare system.
Taking place at Olympia London from 18-19 March 2019, Future Healthcare gathers more than 4,000 attendees from 65 countries for two days of education, cross border purchasing and deal making.

The only B2B event in the UK to showcase healthcare products and services across all sectors to an audience of global buyers.
Provide a product or service to the healthcare industry? You need to be there.
Showcase your products and services at the UK’s only healthcare event attracting buyers from 65 countries.

Organised in association with the UK International Healthcare Management Association, Future Healthcare has emerged as an epicentre for VIP buyers from all over the world. Each year policy makers, practitioners, investors and suppliers gather at Olympia London for cross border purchasing and deal making.
Book a stand today to showcase your products and services to over 4,000 decision makers from 65 countries.

Health Economics (Online Workshop)
2019-03-20 01:30 - 16:30
Health Technology Wales (HTW) has collaborated with Life Sciences Hub Wales (LSHW) to introduce you to key concepts and methods in Health Technology Assessment and Health Economics, through two interactive and free workshops.
Advances in health technologies will have a major impact on the future of health and social care in Wales.
Both workshops will use live examples from HTW, the body responsible for producing national guidance to maximise value and optimise use of technologies that will improve health and care in Wales.
The Health Economics (HE) workshop will introduce you to the methods of economic evaluation used to understand the cost effectiveness and impact on resources of health and care technologies.

EU Medical Device Technical Files Workshop
2019-03-20 08:00 - 17:00 | Hempsons, 100 Wood Street, London, EC2V 7AN, United Kingdom
Why attend
The new EU Medical Device Regulation (MDR) is in its implementation phase and will be effective from May 2020. All medical devices will need to comply with this new legislation. Similarly, the IVD Regulation (IVDR) will be in force from May 2022. Many companies are not yet ready for the journey let alone have a roadmap of how to get to compliance.
This one-day event will:

Provide you with an overview of the key requirements for technical documentation in order to comply with the MDR and your conformity assessment
Assist you in assessing your company’s current preparedness for the transition
Provide a clear, practical guide to the next steps that you and your company need to take to meet Technical documentation requirements to gain CE Marking under the MDR

Outcomes

Gain an overview of the EU MDR Technical Documentation Requirements
Understand the technical documentation that should be in place for each device
Understand the key areas of compliance required
Gain a plan of action for implementation and CE Marking under the new legislation

Target Companies: Medical Device companies and Pharma companies with combination products.
Target Market: C-suite, executives, product owners, medical officers, regulatory and clinical specialists within a company that need to understand the overall requirements of the new Medical Device Regulation for their medical devices to enable them to place a device on the market and to maintain access after May 2020. All company sizes will find it useful, but particularly helpful for smaller, resource constrained organisations

Please note that places are limited & the organisers have the right to review all applications. Confirmation will be sent by 31st May and invoices will be sent separately by SEHTA.
Please note that in compliance with our GDPR policy, by registering for this event, you are automatically added to our mailing list. If you wish to unsubscribe email info@sehta.co.uk with your details.
Agenda

Times
Programme
Speaker

10:30 – 10:45
Registration & Refreshments

10:45 – 10:55
Welcome
Jacques Du Preez, MD, Mosiac Surgical & Director, Psephos Biomedica & Neil Roberts, COO, SEHTA

10:55 – 12:15
Introduction to Technical Files & Design History Files

CE Marking
Conformity Assessment
Overview of Regulations & Requirements
Role of Quality Management System

Robin Stephens, CEO, Psephos Biomedica& Jacques Du Preez, MD, Mosaic Surgical & Director, Psephos Biomedica

12:15 – 13:00
Networking Lunch Break

13:00 – 13:40
MDR Annex II – Technical Documentation
Jacques Du Preez, MD, Mosaic Surgical & Director, Psephos Biomedica

13:40 – 14:10
Annex I – General Safety & Performance Requirements
Jacques Du Preez, MD, Mosaic Surgical & Director, Psephos Biomedica

14:10 – 14:40
Annex III – Technical Documentation on Post Market Survelliance
Robin Stephens, CEO, Psephos Biomedica

14:40- 15:00
Refreshment Break

15:00 – 15:30
Clinical Evidence Introduction
Robin Stephens, CEO, Psephos Biomedica

15:30- 16:00
Roundtable Discussion (inc Q&A)
All

EU MDR Medical Device CE Marking Workshop
2019-03-20 22:30 | Hempsons, 100 Wood Street, London, EC2V 7AN, United Kingdom
SEHTA, Psephos Biomedica & Mosaic Surgical would like to invite you to attend our EU MDR Medical Device CE Marking Workshop.
Date: Wednesday 20 March 2019
Venue: Hempsons, 100 Wood Street, London EC2V 7AN
Times: 10:30 – 16:00
Costs to attend: – You will be invoiced separately after registration
SEHTA Members – £240+ VAT per delegate
SEHTA non-members – £280+ VAT per delegate (it’s free to join SEHTA – Please click here)
Venue kindly supported by

Why attend
To sell a medical device in the UK and Europe it must have the CE mark. This process is currently in transition. The new EU Medical Device Regulation (MDR) is in its implementation phase and will be fully effective from May 2020. All medical devices will need to comply with this new legislation. Companies are starting to make the transition and new technologies are going to need to comply with the new regulations.
This one-day interactive event will provide an overview of:

MDR CE Marking Process and the role of a Notified Body and Competent Authority
MDR Device Classification
MDR Conformity Assessment routes for class I, IIa, IIb and III products
Compiling Technical Files, Clinical Evaluation Reports & the Declaration of Conformity
Eudamed, Labelling and Language translation
MDR Post Market Surveillance & Vigilance

Outcomes

Gain an overview of the new EU Medical Device CE Marking Process
Understand the key areas of compliance required
Understand the technical documentation that should be in place for each device
An opportunity to discuss next steps, action plans and areas requiring clarification

Target Companies:
Medical Device companies and Pharma companies with combination products.

Target Market:
C-suite, executives, product owners, medical officers, regulatory and clinical specialists within a company that need to understand the overall requirements of the new Medical Device Regulation for their medical devices to enable them to place a device on the market and to maintain access after May 2020. All company sizes will find it useful, but particularly helpful for smaller, resource constrained organisations

Please note that places are limited & the organisers have the right to review all applications. Confirmation will be sent by 15th March and invoices will be sent separately by SEHTA.
Please note that in compliance with our GPDR policy, by registering for this event, you are automatically added to our mailing list. If you wish to unsubscribe email info@sehta.co.uk with your details.
Agenda

Times
Programme

Speaker

10:30 – 10:45
Registration & Refreshments

10:45 – 10:55
Welcome
Jacques Du Preez, MD, Mosaic Surgical & Neil Roberts, COO, SEHTA

10:55 – 11:35
CE Marking Overview
Robin Stephens, CEO, Psephos Biomedica

11:35 – 12:15
Device Classification
Jacques Du Preez

12:15 – 13:00
Networking Lunch

13:00 – 13:40
Conformity Assessment Route
Robin Stephens

13:40 – 14:10
Tech Files, Clinical Evaluation Reports, Declaration of Conformity
Jacques Du Preez

14:10 – 14:40
Labelling & Language
Jacques Du Preez

14:40 – 15:00
Refreshment Break

15:00 – 15:30
Post Market Survelliance & Vigilence
Robin Stephens

15:30 – 16:00
Roundtable discussion inc Q&A

16:00
Close

MPD Training Course: European Medical Device Directive (MDD) Basics and Transition to the Medical Device Regulation (MDR)
2019-03-21 09:00 - 16:30 | MeetPoint Midlands Conference Centre, 28 High Street Kegworth, Derbyshire DE74 2DA
This one-day course is designed for those who need to better understand the MDD and want to learn what is important for compliance in the MDR. The clock is ticking and time is running out. To ensure you are ready for the MDR attend this informative training course.
Comprehensive slides and information will be supplied on the day alongside a wealth of experience, insights, examples and methods.
In just one day the course will cover:
– What is and what is not a medical device
– Who is involved
– Insights into guidance and standards
– What is CE marking and why the ‘Blue Guide’ matters
– An introduction to the MDR plus key considerations and timelines
– Understanding the role of economic operators
– How to classify your device under both MDD and MDR
– How to choose a regulatory route to market and why a quality system approach is important
– What is required in technical documentation
– Labelling insights
– Brief comments on clinical evaluation and MDD2MDR planning considerations
Member cost: £ 200
Non-Member cost: £ 300
EARLY BIRD DISCOUNT: book before 5pm on Friday 22 February and members will pay £160 and non-members will pay £240
All prices are excluding VAT

Registration details: https://www.medilinkem.com/event/mpd-training-course-european-medical-device-directive-mdd-basics-and-transition-to-the-medical-device-regulation-mdr-4/

Organiser of Raymond and Beverly Sackler Public Lecture: Professor Anne Lingford-Hughes 'The brain in addiction – is it different?'
2019-03-21 17:00 - 19:00 | Hadyn Ellis Medical Research Facility, Maindy Road, Cardiff , CF24 4HQ, United Kingdom
We are delighted to announce that Professor Anne Lingford-Hughes, will be delivering our annual Raymond and Beverly Sackler Distinguished Lecture in Neuroscience, established in honour of Professor Sir Keith Peters.
All drugs of abuse alter brain function, but how do they do this, what makes someone vulnerable to addiction and are any changes enduring? This lecture will describe how brain imaging has enabled us to investigate the impact of different drugs of abuse on the brain and how this knowledge helps us develop better prevention and treatment strategies.
Professor Anne Lingford-Hughes leads the Centre for Psychiatry and Addiction Biology at Imperial College London. She is also a Consultant Psychiatrist with a particular interest in pharmacological treatments of alcohol problems and other substance addictions at Central North West London NHS Foundation Trust. Her research has focused on using neuroimaging and neuropharmacological challenges to characterize the neurobiology of addiction. The aim of her research programme is to better understand neurobiology underpinning these disorders to improve treatment.

Programme
5:00 pm- Registration and drinks reception
6:00 pm- Lecture begins
7:00 pm- Close
FAQs
What are my transport/parking options for getting to and from the event?
Please note that car parking at the Hadyn Ellis Building is limited. Disabled parking is available to the side of the building (opposite the Optometry building).
The nearest train station is Cathays (~5 minute walk) and the nearest pay and display on-street parking is on Senghenydd Road or Park Place.
How can I contact the organiser with any questions?
If you have any queries about this event please contact Araya-LarrainC@cardiff.ac.uk

Do I have to bring my printed ticket to the event?
No you do not need to bring your printed ticket, we will have digital registration available.

BIO-Europe Spring 2019
2019-03-25 - 2019-03-27 | Unnamed Venue, Vienna
The premier springtime partnering conference bringing together a “whoʼs who from biotech, pharma and finance in Europe’s most innovative biopharma clusters. Hear key biotech and pharma leaders discuss the latest industry trends in workshops and panels. Sponsor or Exhibit to position your company among the innovators of the life science industry. Get the latest news and gain an in-depth look at the people and topics behind life science partnering.
$350 discount on registration for ULS members.
Find out more here

Inside Oxford Nanopore: The UK’s gene-sequencing “unicorn”
2019-03-27 17:15 - 19:30 | Hadyn Ellis Medical Research Facility, Maindy Road, Cardiff, CF24 4HQ, United Kingdom
Dr Gordon Sanghera started his higher education in Cardiff, where his chemistry degree was a solid foundation for a PhD in bioelectronics at Cardiff with Prof JDR Thomas, and subsequently a career in the business of marrying biology, chemistry and electronics to create innovative breakthroughs in blood glucose sensing and DNA analysis.
Gordon along with Hagan Bayley and IP Group was co-founder of Oxford Nanopore. He was appointed CEO in June 2005. Oxford Nanopore aims to enable the analysis of any living thing, by any person, in any environment. The Company’s first device, the MinION, is the only portable, real time DNA/RNA sequencer. In use in more than 70 countries, it is being used in the analysis of pathogens, human disease, crop science and environmental surveillance. The MinION is even being used to perform microbiology experiments on the international space station.
Oxford Nanopore now has more than 350 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The company has raised more than £451M to date and is currently well funded for the next phase of corporate development.
As Oxford Nanopore’s products scale upwards to be suitable for large scale population genomics projects, and downwards to potentially provide rapid tests at the point of care, what are the implications for industry, healthcare and even education? And how should an emerging British technology company approach disrupting global markets?
Join us for this Cardiff University Innovation Network event, where Dr Sanghera will discuss these points and answer questions.
There will be a Q&A session following the presentation.
Networking – Canapes and networking will be available from 5.30pm.
Booking – Attendance at this event is free, but booking is required. Places will be allocated on a first come basis.
Registration – Registration will open at 5.30 pm. The session will start promptly at 6.00pm.

Prepare to Raise Funds for your Business and the Legal Implications
2019-03-28 08:00 - 10:30 | BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF, United Kingdom
This breakfast event in partnership with Mills & Reeve will provide an invaluable opportunity to find out how to fund and protect your R&D.
Programme to follow.
Mills and Reeve are Proud Patrons of Medilink EM, to read about the company and Patronage click here.

Infectious Diseases Special Interest Group (SIG)
2019-04-03 09:00 - 14:00 | Unnamed Venue, Leicester
Probiotics and the Gut Microbiome.
As part of a two part special interest group initiative, Farm to Fork, with our sister SIG, Food Supplements. We are looking at the nutrition perspective of microbiology, namely probiotics and why a healthy gut is important. Micro-organisms are integral to our health and wellbeing. In these two networking meetings we shall be exploring how the role of micro-organisms both good and bad are pivotal to our continued health.
3 April – The Infectious Disease SIG will explore the links between food production and antibiotic resistance in the environment and the impact this can have on health.
This free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project.
7 March – This event will look at the impact of the microbiome, influence of probiotics (what they are and how they are regulated) and how to innovate in this area. Click here for further details.
Please note: Individual registration is required for each event. By clicking BOOK NOW you will be registered for 3 April only.
Programme to follow

Britain in South East Asia Roadshow - Welsh Government
2019-04-10 08:30 - 16:00
EXPLORE EXPORT OPPORTUNITIES IN SOUTH EAST ASIA
Cost: Free
The Welsh Government is hosting the Britain in South East Asia Roadshow. At this event, you have the opportunity to:
Meetings with market experts from

Malaysia
Singapore
Vietnam
Thailand
Indonesia
Philippines

Attend workshops on doing business in South East Asia, covering topics such as payments, opportunities, finance and protecting IP.
Meet with export service suppliers, including Welsh Government Export Team.
Spaces are limited, so sign up early to reserve your place to avoid disappointment.
Please choose your preferred markets and appointment time below.
Open to all Welsh businesses with international growth ambitions. Not for intermediaries or suppliers of international trade services.

Your company name and contact details will be shared with our event partners, UK ASEAN Business Council (UK ABC) Britain in South East Asia (BISEA) to assist with the preparation of information and support for attendees. These details will only be used for this event.

CITER Research Workshop: Digitial Technology Rehabilitation
2019-04-10 09:00 - 16:00 | Hadyn Ellis Medical Research Facility, Maindy Road, Cardiff
Digital technology applications in rehabilitation have become increasingly popular for addressing clinical problems. This is a fantastic opportunity for the specialists in the field to meet and discuss the benefits and drawbacks that digital technology may bring to the rehabilitation field, and to suggest research topics that should be tackled in the near future.
This workshop brings together communities from researchers, technologists, and clinicians to encourage presentation and discussion of ongoing work in this field.
The aim of this workshop is to foster knowledge and experience exchange on how various technologies can uptake rehabilitation and patients’ quality of life.
The main objectives of this workshop are:

To share knowledge on overcoming challenges and barriers to development of digital technology applications related to rehabilitation.
To gain insights into the latest digital technology developments, opinions and its current place in rehabilitation.
To provide opportunity for networking with colleagues and presenters and contribute to wider thinking on the future role of digital technology in rehabilitation.
To learn from current users of the digital technology to inform the development of plans for establishing a cross-disciplinary research related to rehabilitation.

KEY NOTE SPEAKERS:
Emer Doheny, Universty College Dublin
Professor Lynne Baillie, Heriot-Wat University, Edinburgh
**ATTENTION Post Doctorate Research Asscoiates / PhD student: During the workshop there will be a one hour PechaKucha Style Research Presentation session targeted at PhD students and Postdoctoral Research Associates. Within each talk 20 slides are shown for 20 seconds each (6 mins and 40 secs in total). If you are interested in presenting, please note the deadline to contact citer@cardiff.ac.uk is 10.03.19.
Delegates are encouraged to bring a poster to showcase their research, please confirm on your registration form. There will be a best poster prize awarded as part of the workshop.
The NEW CITER outreach activity: “Virtual Rehabilitation Games” will be demonstrated during the lunchbreak.
KEYNOTE SPEAKER: TBC

Entry is free of charge to CITER members.
£30 fee for external CITER members.
PLEASE ENSURE YOU REGISTER YOUR PLACE ON EVENTBRITE AND BRING THE TICKET CONFIRMATION WITH YOU ON THE DAY: https://www.eventbrite.com/e/citer-research-workshop-digitial-technology-rehabilitation-tickets-52406868354?aff= – use the password = [REDACTED]
Refreshments and lunch will be provided.

New to Welsh Life Sciences: Partnering event for investors and life science companies
2019-04-12 09:30 - 13:30 | Capital Law, Tyndall Street, Cardiff, CF10 4AZ
The first in our “Finance and Funding Events” series, we are collaborating with BIC Innovation to deliver a ‘Meet the Investor’ partnering event in Cardiff on 12th April.

Life Science companies looking for investment: an opportunity to engage with key investor organisations

Severn Seed Finance
Angels Invest Wales
Dawson Partnership
Barclays
NatWest Cymru
Maven Capital Partners

– 1-to -1 face to face meetings with investors
– Pre-arranged ahead of the day
– Opportunity for up to 8 consecutive meetings

Free to attend for MediWales members

Registrations close Wednesday 3rd April 2019 – Get in touch now to book your place

Final Programme:

9.30: Registration & coffee
9.45: Meeting introduction Chaired by Capital Law & BIC Innovation
9.55: Capital Law
10.00: MediWales
10.05: BIC Innovation
10.10: 1-2-1 Meetings (15 mins per meeting)
12.15: Summary & feedback chaired by Gwyn Tudor
12.30 Light lunch & informal networking

BioTrinity 2019
2019-04-29 - 2019-05-01 | Unnamed Venue, London
CALLING ALL LIFE SCIENCES LEADERS! PDF
BioTrinity 2019 will take place in London on April 29th – May 1st and will include revisions made on the basis of feedback from delegates at BioTrinity 2018
and innovations from the OBN Team. Our aim is to continue to provide a unique opportunity for interactions between investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to strike deals and grow their networks.
BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors.
10% discount on registration for members.
Find out more here
